| Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes (NCT00613951) | Novo Nordisk A/S | 2008-01-01 |
| Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin (NCT00670722) | Novo Nordisk A/S | 2008-01-01 |
| Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (NCT01762046) | Massachusetts General Hospital | 2008-01-01 |
| Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00614120) | Novo Nordisk A/S | 2008-01-01 |
| Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509 (NCT00665145) | Sangamo Therapeutics | 2008-01-01 |
| Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (NCT00616811) | Novartis | 2008-01-01 |
| Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes (NCT00611884) | Novo Nordisk A/S | 2008-01-01 |
| Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo. (NCT00537719) | GlaxoSmithKline | 2007-12-07 |
| Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness (NCT00573950) | Korea University Anam Hospital | 2007-12-01 |
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes (NCT00671008) | Novo Nordisk A/S | 2007-12-01 |
| A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes (NCT00672386) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-12-01 |
| Implementation of a Diabetes Management Protocol as Compared to Conventional Management in a Heart Hospital's Non-Intensive Care Unit: Randomized Clinical (NCT01154413) | Instituto de Cardiologia do Rio Grande do Sul | 2007-12-01 |
| First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050 (NCT00607906) | GlaxoSmithKline | 2007-11-16 |
| Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease (NCT00552903) | Paijat-Hame Hospital District | 2007-11-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide (NCT00560417) | Eli Lilly and Company | 2007-11-01 |
| Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea (NCT00455858) | Novo Nordisk A/S | 2007-11-01 |
| Phase I Multiple-Ascending Dose (Japan) (NCT00538174) | AstraZeneca | 2007-11-01 |
| Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin (NCT00669864) | Novo Nordisk A/S | 2007-11-01 |
| Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge Matrix (NCT00948584) | Hallym University Medical Center | 2007-11-01 |
| Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard® (NCT00658099) | Novo Nordisk A/S | 2007-11-01 |
| A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects (NCT00559884) | GlaxoSmithKline | 2007-11-01 |
| Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes (NCT01384058) | University Hospital Freiburg | 2007-11-01 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) (NCT00509236) | Merck Sharp & Dohme LLC | 2007-10-19 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) (NCT00509262) | Merck Sharp & Dohme LLC | 2007-10-09 |
| Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes (NCT00537303) | Novo Nordisk A/S | 2007-10-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs (NCT00537277) | Novo Nordisk A/S | 2007-10-01 |
| Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany (NCT00665808) | Novo Nordisk A/S | 2007-10-01 |
| REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (NCT00546325) | Sanofi | 2007-10-01 |
| Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins (NCT00657319) | Novo Nordisk A/S | 2007-10-01 |
| Effects of Walnut Consumption on Endothelial Function in Type 2 Diabetes (NCT00901043) | Griffin Hospital | 2007-10-01 |
| Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes (NCT00698126) | Novo Nordisk A/S | 2007-10-01 |
| A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus (NCT00521378) | Diasome Pharmaceuticals | 2007-09-17 |
| A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin (NCT00519480) | GlaxoSmithKline | 2007-09-11 |
| A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults (NCT00532610) | GlaxoSmithKline | 2007-09-01 |
| A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. (NCT00517465) | Hoffmann-La Roche | 2007-09-01 |
| An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching Insulin (NCT00549887) | Eli Lilly and Company | 2007-09-01 |
| A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes (NCT00570687) | Mannkind Corporation | 2007-09-01 |
| Sympathetic Activity and Cardiometabolic Complications (NCT04495231) | University of Turin, Italy | 2007-09-01 |
| The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial (NCT00910507) | University of Central Arkansas | 2007-09-01 |
| Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes (NCT00712478) | Novo Nordisk A/S | 2007-09-01 |
| Continuous Glucose Monitoring in Patients With Type 2 Diabetes (NCT00529815) | Walter Reed Army Medical Center | 2007-09-01 |
| Observational Study to Evaluate the Safety of Levemir® in Diabetes (NCT00706017) | Novo Nordisk A/S | 2007-09-01 |
| Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus (NCT00446810) | Ruhr University of Bochum | 2007-09-01 |
| Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma (NCT00523042) | Novo Nordisk A/S | 2007-08-30 |
| Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive (NCT00495469) | GlaxoSmithKline | 2007-08-17 |
| Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes (NCT00527397) | Pfizer | 2007-08-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE) (NCT00510952) | Eli Lilly and Company | 2007-08-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) (NCT00494013) | Eli Lilly and Company | 2007-08-01 |
| Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects (NCT00638313) | Pfizer | 2007-08-01 |
| Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus (NCT00530309) | GlaxoSmithKline | 2007-08-01 |
| Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus (NCT00519142) | Elixir Pharmaceuticals | 2007-08-01 |
| Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic Individuals (NCT02400515) | University of Campinas, Brazil | 2007-08-01 |
| Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00518882) | Novo Nordisk A/S | 2007-08-01 |
| Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes (NCT00824668) | Novo Nordisk A/S | 2007-08-01 |
| New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I (NCT00566189) | University of Campinas, Brazil | 2007-08-01 |
| Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate (NCT00551564) | GlaxoSmithKline | 2007-07-31 |
| A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes. (NCT00502710) | Hoffmann-La Roche | 2007-07-01 |
| Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy (NCT00515632) | Rheoscience A/S | 2007-07-01 |
| GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes (NCT00509223) | ResMed | 2007-07-01 |
| Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus (NCT01030679) | Chong Kun Dang Pharmaceutical | 2007-07-01 |
| 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin (NCT00473525) | Pfizer | 2007-07-01 |
| Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) (NCT00485758) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes (NCT00506662) | Novo Nordisk A/S | 2007-07-01 |
| Dose-Range Finding Study for MK0893 (0893-008) (NCT00479466) | Merck Sharp & Dohme LLC | 2007-07-01 |
| A Study for Patients With Type 2 Diabetes Mellitus (NCT00490854) | Eli Lilly and Company | 2007-07-01 |
| The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin (NCT00529165) | University of Jena | 2007-07-01 |
| Observational Study of Patients With Diabetes Using Levemir® FlexPen® (NCT00670683) | Novo Nordisk A/S | 2007-07-01 |
| Observational Study to Evaluate the Safety While Using Levemir® (NCT00701155) | Novo Nordisk A/S | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets (NCT01924767) | Boehringer Ingelheim | 2007-07-01 |
| A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function (NCT00501462) | GlaxoSmithKline | 2007-07-01 |
| Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study (NCT00566215) | University of Campinas, Brazil | 2007-07-01 |
| Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus (NCT00445627) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2007-06-18 |
| Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects (NCT03144271) | Novo Nordisk A/S | 2007-06-11 |
| Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™ (NCT00675220) | Novo Nordisk A/S | 2007-06-01 |
| CDRM Study: Computer-assisted Diabetes Risk Management-for Secondary and Tertiary Prevention of T2DM Complications (NCT01556529) | Philipps University Marburg | 2007-06-01 |
| Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control (NCT00700960) | Novo Nordisk A/S | 2007-06-01 |
| ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria (NCT01375322) | TSH Biopharm Corporation Limited | 2007-06-01 |
| 4 Weeks Treatment of Type II Diabetic Patients With BI 44847 (NCT00558909) | Boehringer Ingelheim | 2007-06-01 |
| Effects of Qigong on Type 2 Diabetic Patients (NCT00885846) | Bastyr University | 2007-06-01 |
| A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus (NCT00963768) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06-01 |
| A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera. (NCT00437489) | Pfizer | 2007-06-01 |
| Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin (NCT00494884) | Novartis | 2007-06-01 |
| Randomized Crossover Study of Magnesium Supplementation (NCT00737815) | University of California, Los Angeles | 2007-06-01 |
| A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. (NCT00461006) | Hoffmann-La Roche | 2007-06-01 |
| Variation in Sulphonylurea Response in Type 2 Diabetes (NCT00738088) | NHS Tayside | 2007-06-01 |
| Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) (NCT00472953) | Novo Nordisk A/S | 2007-05-15 |
| Screening for Early Evidence of Diabetes (NCT00614783) | VeraLight, Inc. | 2007-05-01 |
| A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes (NCT01606371) | Eli Lilly and Company | 2007-05-01 |
| Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (NCT00655044) | Novo Nordisk A/S | 2007-05-01 |
| Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes (NCT00715351) | Novo Nordisk A/S | 2007-05-01 |
| A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure. (NCT00461058) | Hoffmann-La Roche | 2007-05-01 |
| Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy (NCT00476931) | Sangamo Therapeutics | 2007-05-01 |
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes (NCT00665093) | Novo Nordisk A/S | 2007-05-01 |
| A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes (NCT00474630) | Orexigen Therapeutics, Inc | 2007-05-01 |
| Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study (NCT00481429) | Imperial College London | 2007-05-01 |
| Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes (NCT00469092) | Novo Nordisk A/S | 2007-05-01 |
| Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes (NCT00469586) | Novo Nordisk A/S | 2007-04-26 |
| A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin. (NCT00460941) | Hoffmann-La Roche | 2007-04-01 |
| DOMME Dose Optimization Multicentric Mexican Evaluation (NCT00488527) | Sanofi | 2007-04-01 |
| A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers (NCT00501930) | GlaxoSmithKline | 2007-04-01 |